Atlas Trials

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Clinical trial NCT03843853 · WITHDRAWN

Trial details

NCT number
NCT03843853
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Neoplasms
Start date
2019-05-01
Primary completion
2021-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.